{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:47:19Z","timestamp":1791935239656,"version":"4.3.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["860977"],"award-info":[{"award-number":["860977"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94855-9","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T05:27:57Z","timestamp":1742966877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["PKD1 mutation perturbs morphogenesis in tubular epithelial organoids derived from human pluripotent stem cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Alexandru","family":"Scarlat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Trionfini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Longaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Breno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Longhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christodoulos","family":"Xinaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela","family":"Benigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Tomasoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"94855_CR1","first-page":"1356","volume":"32","author":"CJ Willey","year":"2017","unstructured":"Willey, C. J. et al. Prevalence of autosomal dominant polycystic kidney disease in the European union. Nephrol. Dial Transpl. 32, 1356\u20131363 (2017).","journal-title":"Nephrol. Dial Transpl."},{"key":"94855_CR2","doi-asserted-by":"publisher","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","volume":"29","author":"EM Spithoven","year":"2014","unstructured":"Spithoven, E. M. et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival\u2014an analysis of data from the ERA-EDTA registry. Nephrol. Dial. Transplant.  29, iv15\u2013iv25 (2014).","journal-title":"Nephrol. Dialysis Transplantation"},{"key":"94855_CR3","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres, V. E., Harris, P. C. & Pirson, Y. Autosomal dominant polycystic kidney disease. Lancet 369, 1287\u20131301 (2007).","journal-title":"Lancet"},{"key":"94855_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","volume":"353","author":"N Hateboer","year":"1999","unstructured":"Hateboer, N. et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 study group. Lancet 353, 103\u2013107 (1999).","journal-title":"Lancet"},{"key":"94855_CR5","first-page":"195","volume":"30","author":"T Saigusa","year":"2015","unstructured":"Saigusa, T. & Bell, P. D. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease. Physiol. (Bethesda). 30, 195\u2013207 (2015).","journal-title":"Physiol. (Bethesda)"},{"key":"94855_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ng1076","volume":"33","author":"SM Nauli","year":"2003","unstructured":"Nauli, S. M. et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33, 129\u2013137 (2003).","journal-title":"Nat. Genet."},{"key":"94855_CR7","doi-asserted-by":"publisher","first-page":"F930","DOI":"10.1152\/ajprenal.00285.2006","volume":"292","author":"C Xu","year":"2007","unstructured":"Xu, C. et al. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2\u2009+\u2009signaling. Am. J. Physiol. Ren. Physiol. 292, F930\u2013945 (2007).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"94855_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1681\/ASN.2013040398","volume":"25","author":"VE Torres","year":"2014","unstructured":"Torres, V. E. & Harris, P. C. Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. J. Am. Soc. Nephrol. 25, 18\u201332 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"94855_CR9","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres, V. E. et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl. J. Med. 367, 2407\u20132418 (2012).","journal-title":"N Engl. J. Med."},{"key":"94855_CR10","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","volume":"377","author":"VE Torres","year":"2017","unstructured":"Torres, V. E. et al. Tolvaptan in Later-Stage autosomal dominant polycystic kidney disease. N Engl. J. Med. 377, 1930\u20131942 (2017).","journal-title":"N Engl. J. Med."},{"key":"94855_CR11","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","volume":"382","author":"A Caroli","year":"2013","unstructured":"Caroli, A. et al. Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. Lancet 382, 1485\u20131495 (2013).","journal-title":"Lancet"},{"key":"94855_CR12","doi-asserted-by":"publisher","first-page":"e1002777","DOI":"10.1371\/journal.pmed.1002777","volume":"16","author":"N Perico","year":"2019","unstructured":"Perico, N. et al. Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial. PLoS Med. 16, e1002777 (2019).","journal-title":"PLoS Med."},{"key":"94855_CR13","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1681\/ASN.2018060590","volume":"29","author":"FT Chebib","year":"2018","unstructured":"Chebib, F. T. et al. A practical guide for treatment of rapidly progressive ADPKD with Tolvaptan. J. Am. Soc. Nephrol. 29, 2458\u20132470 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"94855_CR14","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cgh.2015.12.049","volume":"14","author":"A Pisani","year":"2016","unstructured":"Pisani, A. et al. Long-term effects of octreotide on liver volume in patients with polycystic kidney and liver disease. Clin. Gastroenterol. Hepatol. 14, 1022\u20131030e4 (2016).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"94855_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijcard.2018.10.063","volume":"275","author":"L Spinelli","year":"2019","unstructured":"Spinelli, L. et al. Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: A cross-sectional and longitudinal substudy of the ALADIN trial. Int. J. Cardiol. 275, 145\u2013151 (2019).","journal-title":"Int. J. Cardiol."},{"key":"94855_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2215\/CJN.0000000000000049","volume":"18","author":"M Trillini","year":"2023","unstructured":"Trillini, M. et al. Effects of Octreotide-Long-Acting release Added-on Tolvaptan in patients with autosomal dominant polycystic kidney disease: pilot, randomized, Placebo-Controlled, Cross-Over trial. Clin. J. Am. Soc. Nephrol. 18, 223\u2013233 (2023).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"94855_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrneph.2015.39","volume":"11","author":"FT Chebib","year":"2015","unstructured":"Chebib, F. T., Sussman, C. R., Wang, X., Harris, P. C. & Torres, V. E. Vasopressin and disruption of calcium signalling in polycystic kidney disease. Nat. Rev. Nephrol. 11, 451\u2013464 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"94855_CR18","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.3390\/ijms21124537","volume":"21","author":"S Koslowski","year":"2020","unstructured":"Koslowski, S., Latapy, C., Auvray, P., Blondel, M. & Meijer, L. An overview of in vivo and in vitro models for autosomal dominant polycystic kidney disease: A journey from 3D-Cysts to Mini-Pigs. Int. J. Mol. Sci. 21, 4537 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"94855_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrneph.2014.137","volume":"10","author":"H Happ\u00e9","year":"2014","unstructured":"Happ\u00e9, H. & Peters, D. J. M. Translational research in ADPKD: lessons from animal models. Nat. Rev. Nephrol. 10, 587\u2013601 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"94855_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/bs.mcb.2019.05.008","volume":"153","author":"M Sharma","year":"2019","unstructured":"Sharma, M., Reif, G. A. & Wallace, D. P. In vitro cyst formation of ADPKD cells. Methods Cell. Biol. 153, 93\u2013111 (2019).","journal-title":"Methods Cell. Biol."},{"key":"94855_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres, V. E. & Harris, P. C. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 76, 149\u2013168 (2009).","journal-title":"Kidney Int."},{"key":"94855_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ebiom.2018.06.005","volume":"33","author":"V Benedetti","year":"2018","unstructured":"Benedetti, V. et al. Engineered kidney tubules for modeling Patient-Specific diseases and drug discovery. EBioMedicine 33, 253\u2013268 (2018).","journal-title":"EBioMedicine"},{"key":"94855_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"94855_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/physrev.00039.2017","volume":"99","author":"P Karagiannis","year":"2019","unstructured":"Karagiannis, P. et al. Induced pluripotent stem cells and their use in human models of disease and development. Physiol. Rev. 99, 79\u2013114 (2019).","journal-title":"Physiol. Rev."},{"key":"94855_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.scr.2016.06.001","volume":"17","author":"O Ciampi","year":"2016","unstructured":"Ciampi, O. et al. Generation of functional podocytes from human induced pluripotent stem cells. Stem Cell. Res. 17, 130\u2013139 (2016).","journal-title":"Stem Cell. Res."},{"key":"94855_CR26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1681\/ASN.2018070747","volume":"30","author":"Y Yoshimura","year":"2019","unstructured":"Yoshimura, Y. et al. Manipulation of Nephron-Patterning signals enables selective induction of podocytes from human pluripotent stem cells. J. Am. Soc. Nephrol. 30, 304\u2013321 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"94855_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.stem.2013.11.010","volume":"14","author":"A Taguchi","year":"2014","unstructured":"Taguchi, A. et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell. Stem Cell. 14, 53\u201367 (2014).","journal-title":"Cell. Stem Cell."},{"key":"94855_CR28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature15695","volume":"526","author":"M Takasato","year":"2015","unstructured":"Takasato, M. et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526, 564\u2013568 (2015).","journal-title":"Nature"},{"key":"94855_CR29","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/nbt.3392","volume":"33","author":"R Morizane","year":"2015","unstructured":"Morizane, R. et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat. Biotechnol. 33, 1193\u20131200 (2015).","journal-title":"Nat. Biotechnol."},{"key":"94855_CR30","doi-asserted-by":"publisher","first-page":"107963","DOI":"10.1016\/j.celrep.2020.107963","volume":"32","author":"SI Mae","year":"2020","unstructured":"Mae, S. I. et al. Expansion of human iPSC-Derived ureteric bud organoids with repeated branching potential. Cell. Rep. 32, 107963 (2020).","journal-title":"Cell. Rep."},{"key":"94855_CR31","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.stem.2017.10.011","volume":"21","author":"A Taguchi","year":"2017","unstructured":"Taguchi, A. & Nishinakamura, R. Higher-Order kidney organogenesis from pluripotent stem cells. Cell. Stem Cell. 21, 730\u2013746e6 (2017).","journal-title":"Cell. Stem Cell."},{"key":"94855_CR32","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1038\/s41467-021-23911-5","volume":"12","author":"Z Zeng","year":"2021","unstructured":"Zeng, Z. et al. Generation of patterned kidney organoids that recapitulate the adult kidney collecting duct system from expandable ureteric bud progenitors. Nat. Commun. 12, 3641 (2021).","journal-title":"Nat. Commun."},{"key":"94855_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-022-01429-5","volume":"41","author":"M Shi","year":"2023","unstructured":"Shi, M. et al. Human ureteric bud organoids recapitulate branching morphogenesis and differentiate into functional collecting duct cell types. Nat. Biotechnol. 41, 252\u2013261 (2023).","journal-title":"Nat. Biotechnol."},{"key":"94855_CR34","doi-asserted-by":"publisher","unstructured":"Mae, S. I. et al. Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD. Cell. Rep.  https:\/\/doi.org\/10.1016\/j.celrep.2023.113431 (2023).","DOI":"10.1016\/j.celrep.2023.113431"},{"key":"94855_CR35","doi-asserted-by":"publisher","first-page":"8715","DOI":"10.1038\/ncomms9715","volume":"6","author":"BS Freedman","year":"2015","unstructured":"Freedman, B. S. et al. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat. Commun. 6, 8715 (2015).","journal-title":"Nat. Commun."},{"key":"94855_CR36","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.bbrc.2020.06.141","volume":"529","author":"T Shimizu","year":"2020","unstructured":"Shimizu, T. et al. A novel ADPKD model using kidney organoids derived from disease-specific human iPSCs. Biochem. Biophys. Res. Commun. 529, 1186\u20131194 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"94855_CR37","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1681\/ASN.2020030378","volume":"31","author":"S Kuraoka","year":"2020","unstructured":"Kuraoka, S. et al. PKD1-Dependent renal cystogenesis in human induced pluripotent stem Cell-Derived ureteric bud\/collecting duct organoids. J. Am. Soc. Nephrol. 31, 2355\u20132371 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"94855_CR38","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/nmat4994","volume":"16","author":"NM Cruz","year":"2017","unstructured":"Cruz, N. M. et al. Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease. Nat. Mater. 16, 1112\u20131119 (2017).","journal-title":"Nat. Mater."},{"key":"94855_CR39","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/ncb2872","volume":"15","author":"Y Xia","year":"2013","unstructured":"Xia, Y. et al. Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells. Nat. Cell. Biol. 15, 1507\u20131515 (2013).","journal-title":"Nat. Cell. Biol."},{"key":"94855_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/bies.20357","volume":"28","author":"F Costantini","year":"2006","unstructured":"Costantini, F. & Shakya, R. GDNF\/Ret signaling and the development of the kidney. Bioessays 28, 117\u2013127 (2006).","journal-title":"Bioessays"},{"key":"94855_CR41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/ndt\/17.suppl_9.78","volume":"17 Suppl 9","author":"T Gilbert","year":"2002","unstructured":"Gilbert, T. Vitamin A and kidney development. Nephrol. Dial Transpl. 17 Suppl 9, 78\u201380 (2002).","journal-title":"Nephrol. Dial Transpl."},{"key":"94855_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/83792","volume":"27","author":"E Batourina","year":"2001","unstructured":"Batourina, E. et al. Vitamin A controls epithelial\/mesenchymal interactions through Ret expression. Nat. Genet. 27, 74\u201378 (2001).","journal-title":"Nat. Genet."},{"key":"94855_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jdermsci.2011.03.010","volume":"63","author":"T Kawakami","year":"2011","unstructured":"Kawakami, T., Kumasaka, M., Kato, M., Mizoguchi, M. & Soma, Y. BMP-4 down-regulates the expression of Ret in murine melanocyte precursors. J. Dermatol. Sci. 63, 66\u201369 (2011).","journal-title":"J. Dermatol. Sci."},{"key":"94855_CR44","doi-asserted-by":"publisher","first-page":"101881","DOI":"10.1016\/j.scr.2020.101881","volume":"47","author":"E Romano","year":"2020","unstructured":"Romano, E., Trionfini, P., Ciampi, O., Benigni, A. & Tomasoni, S. Generation of PKD1 mono-allelic and bi-allelic knockout iPS cell lines using CRISPR-Cas9 system. Stem Cell. Res. 47, 101881 (2020).","journal-title":"Stem Cell. Res."},{"key":"94855_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0925-4773(01)00592-5","volume":"109","author":"J Qiao","year":"2001","unstructured":"Qiao, J. et al. Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis. Mech. Dev. 109, 123\u2013135 (2001).","journal-title":"Mech. Dev."},{"key":"94855_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ydbio.2008.02.010","volume":"317","author":"D Bridgewater","year":"2008","unstructured":"Bridgewater, D. et al. Canonical WNT\/beta-catenin signaling is required for ureteric branching. Dev. Biol. 317, 83\u201394 (2008).","journal-title":"Dev. Biol."},{"key":"94855_CR47","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1016\/j.celrep.2018.08.056","volume":"24","author":"P Wang","year":"2018","unstructured":"Wang, P. et al. Dissecting the global dynamic molecular profiles of human fetal kidney development by Single-Cell RNA sequencing. Cell. Rep. 24, 3554\u20133567e3 (2018).","journal-title":"Cell. Rep."},{"key":"94855_CR48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ydbio.2017.02.007","volume":"424","author":"J Grassmeyer","year":"2017","unstructured":"Grassmeyer, J. et al. Elf5 is a principal cell lineage specific transcription factor in the kidney that contributes to Aqp2 and Avpr2 gene expression. Dev. Biol. 424, 77\u201389 (2017).","journal-title":"Dev. Biol."},{"key":"94855_CR49","doi-asserted-by":"publisher","first-page":"E9989","DOI":"10.1073\/pnas.1710964114","volume":"114","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. Transcriptomes of major renal collecting duct cell types in mouse identified by single-cell RNA-seq. Proc. Natl. Acad. Sci. 114, E9989\u2013E9998 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"94855_CR50","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.bbadis.2011.01.011","volume":"1812","author":"S Terryn","year":"2011","unstructured":"Terryn, S., Ho, A., Beauwens, R. & Devuyst, O. Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease. Biochimi. Biophys. Acta  1812, 1314\u20131321 (2011).","journal-title":"Biochimica Et Biophys. Acta (BBA) - Molecular Basis Disease"},{"key":"94855_CR51","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1091\/mbc.e10-12-0994","volume":"22","author":"CE Larkins","year":"2011","unstructured":"Larkins, C. E., Aviles, G. D. G., East, M. P., Kahn, R. A. & Caspary, T. Arl13b regulates ciliogenesis and the dynamic localization of Shh signaling proteins. MBoC 22, 4694\u20134703 (2011).","journal-title":"MBoC"},{"key":"94855_CR52","first-page":"F169","volume":"271","author":"O Devuyst","year":"1996","unstructured":"Devuyst, O. et al. Expression of aquaporins-1 and \u2013\u20092 during nephrogenesis and in autosomal dominant polycystic kidney disease. Am. J. Physiol. 271, F169\u2013183 (1996).","journal-title":"Am. J. Physiol."},{"key":"94855_CR53","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/ki.2008.111","volume":"73","author":"PG Starremans","year":"2008","unstructured":"Starremans, P. G. et al. A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5\u2019 end of Pkd1. Kidney Int. 73, 1394\u20131405 (2008).","journal-title":"Kidney Int."},{"key":"94855_CR54","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1172\/JCI64313","volume":"122","author":"K Hopp","year":"2012","unstructured":"Hopp, K. et al. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. J. Clin. Invest. 122, 4257\u20134273 (2012).","journal-title":"J. Clin. Invest."},{"key":"94855_CR55","unstructured":"Lopes, F. M. & Woolf, A. S. Kidney development. in Heptinstall\u2019s Pathology of the Kidney 169\u2013214 (Wolters Kluwer, 2023)."},{"key":"94855_CR56","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41385-022-00565-0","volume":"15","author":"NV Jafari","year":"2022","unstructured":"Jafari, N. V. & Rohn, J. L. The urothelium: a multi-faceted barrier against a harsh environment. Mucosal Immunol. 15, 1127\u20131142 (2022).","journal-title":"Mucosal Immunol."},{"key":"94855_CR57","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.stem.2020.12.001","volume":"28","author":"SE Howden","year":"2021","unstructured":"Howden, S. E. et al. Plasticity of distal nephron epithelia from human kidney organoids enables the induction of ureteric tip and stalk. Cell. Stem Cell. 28, 671\u2013684e6 (2021).","journal-title":"Cell. Stem Cell."},{"key":"94855_CR58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/sj.ki.5002229","volume":"72","author":"E Parker","year":"2007","unstructured":"Parker, E. et al. Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras\/Raf signalling system. Kidney Int. 72, 157\u2013165 (2007).","journal-title":"Kidney Int."},{"key":"94855_CR59","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.stem.2022.06.005","volume":"29","author":"T Tran","year":"2022","unstructured":"Tran, T. et al. A scalable organoid model of human autosomal dominant polycystic kidney disease for disease mechanism and drug discovery. Cell. Stem Cell. 29, 1083\u20131101e7 (2022).","journal-title":"Cell. Stem Cell."},{"key":"94855_CR60","doi-asserted-by":"publisher","first-page":"7918","DOI":"10.1038\/s41467-022-35537-2","volume":"13","author":"SR Li","year":"2022","unstructured":"Li, S. R. et al. Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease. Nat. Commun. 13, 7918 (2022).","journal-title":"Nat. Commun."},{"key":"94855_CR61","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.semcdb.2020.05.003","volume":"110","author":"M Ma","year":"2021","unstructured":"Ma, M. Cilia and polycystic kidney disease. Semin. Cell. Dev. Biol. 110, 139\u2013148 (2021).","journal-title":"Semin Cell. Dev. Biol."},{"key":"94855_CR62","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ng.2715","volume":"45","author":"M Ma","year":"2013","unstructured":"Ma, M., Tian, X., Igarashi, P., Pazour, G. J. & Somlo, S. Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat. Genet. 45, 1004\u20131012 (2013).","journal-title":"Nat. Genet."},{"key":"94855_CR63","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1681\/ASN.2016020232","volume":"28","author":"A Klingberg","year":"2017","unstructured":"Klingberg, A. et al. Fully automated evaluation of total glomerular number and capillary tuft size in nephritic kidneys using lightsheet microscopy. J. Am. Soc. Nephrol. 28, 452\u2013459 (2017).","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94855-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94855-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94855-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T06:59:01Z","timestamp":1743317941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94855-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94855"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94855-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10375"}}